Attached files

file filename
EX-32.2 - EXHIBIT 32.2 - GB SCIENCES INCex_242308.htm
EX-31.2 - EXHIBIT 31.2 - GB SCIENCES INCex_242306.htm
EX-31.1 - EXHIBIT 31.1 - GB SCIENCES INCex_242305.htm
EX-21.1 - EXHIBIT 21.1 SUBSIDIARIES OF GB SCIENCES, INC. - GB SCIENCES INCex_242304.htm
EX-10.43 - EXHIBIT 10.43 - GB SCIENCES INCex_258922.htm
EX-10.42 - EXHIBIT 10.42 - GB SCIENCES INCex_258921.htm
EX-10.41 - EXHIBIT 10.41 - GB SCIENCES INCex_258920.htm
EX-10.40 - EXHIBIT 10.40 - GB SCIENCES INCex_258919.htm
EX-10.39 - EXHIBIT 10.39 - GB SCIENCES INCex_258918.htm
EX-10.38 - EXHIBIT 10.38 - GB SCIENCES INCex_258917.htm
EX-10.37 - EXHIBIT 10.37 - GB SCIENCES INCex_258916.htm
EX-10.36 - EXHIBIT 10.36 - GB SCIENCES INCex_258915.htm
EX-10.35 - EXHIBIT 10.35 - GB SCIENCES INCex_258914.htm
EX-10.34 - EXHIBIT 10.34 - GB SCIENCES INCex_258913.htm
EX-10.33 - EXHIBIT 10.33 - GB SCIENCES INCex_258912.htm
EX-10.32 - EXHIBIT 10.32 - GB SCIENCES INCex_258911.htm
EX-10.31 - EXHIBIT 10.31 - GB SCIENCES INCex_258910.htm
EX-10.30 - EXHIBIT 10.30 - GB SCIENCES INCex_258909.htm
EX-10.29 - EXHIBIT 10.29 - GB SCIENCES INCex_258908.htm
EX-10.28 - EXHIBIT 10.28 - GB SCIENCES INCex_258907.htm
EX-4.6 - EXHIBIT 4.6 DESCRIPTION OF REGISTRANT'S SECURITIES - GB SCIENCES INCex_258906.htm
10-K - FORM 10-K - GB SCIENCES INCgblx20210331_10k.htm

Exhibit 32.1

 

Certification Pursuant to 18 U.S.C. Section 1350,

As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act Of 2002

 

In connection with the annual report of GB Sciences, Inc. (the “Company”) on Form 10-K for the period ended March 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, John Poss, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that to the best of my knowledge:

 

1. The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

         Date: July 6, 2021

By:

/s/ John Poss

 

 

 

John Poss

 

 

 

Chief Executive Officer